The store will not work correctly when cookies are disabled.
methyl 2-(3-(1,2,3,5,6,7-hexahydros-indacen-4-yl)ureido)acetate
ID: ALA4764712
PubChem CID: 146503703
Max Phase: Preclinical
Molecular Formula: C16H20N2O3
Molecular Weight: 288.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2
Standard InChI: InChI=1S/C16H20N2O3/c1-21-14(19)9-17-16(20)18-15-12-6-2-4-10(12)8-11-5-3-7-13(11)15/h8H,2-7,9H2,1H3,(H2,17,18,20)
Standard InChI Key: GPEUSHWTEKFXMA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
38.8570 -19.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2865 -20.0974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5703 -20.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8561 -20.1010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2458 -20.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5828 -21.4049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4014 -21.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0014 -20.5084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.7148 -20.0947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4298 -20.5057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.7132 -19.2700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.5686 -18.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2830 -19.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8965 -18.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5613 -17.9604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7405 -18.0465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1431 -20.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8581 -20.5030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5714 -20.0893 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.8597 -21.3276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.2864 -20.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
3 2 2 0
2 13 1 0
12 1 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 3 1 0
2 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
10 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.35 | Molecular Weight (Monoisotopic): 288.1474 | AlogP: 1.96 | #Rotatable Bonds: 3 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.69 | CX Basic pKa: ┄ | CX LogP: 2.74 | CX LogD: 2.74 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -0.74 |
References
1. Harrison D,Boutard N,Brzozka K,Bugaj M,Chmielewski S,Cierpich A,Doedens JR,Fabritius CRY,Gabel CA,Galezowski M,Kowalczyk P,Levenets O,Mroczkowska M,Palica K,Porter RA,Schultz D,Sowinska M,Topolnicki G,Urbanski P,Woyciechowski J,Watt AP. (2020) Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors., 30 (23): [PMID:32956781] [10.1016/j.bmcl.2020.127560] |